MatthewCAbramowitzMD

Radiation Oncology • Miami, FL

Central Nervous System Cancer, Head & Neck, Urologic Cancer

Associate Professor, Radiation Oncology, University of Miami School of Medicine

Join to view full profile

Dr. Abramowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abramowitz's full profile

Already have an account?

Office
1475 Nw 12th Ave
Suite 1500
Miami, FL 33136
Phone+1 305-243-4200

Fax+1 305-243-4363

Education & Training

Temple University Hospital/Fox Chase Cancer CenterResidency, Radiation Oncology, 2004 - 2008
Crozer-Chester Medical CenterInternship, Transitional Year, 2003 - 2004
Lewis Katz School of Medicine at Temple UniversityClass of 2003

Certifications & Licensure

FL State Medical License 2008 - 2026
PA State Medical License 2003 - 2014
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial Start of enrollment: 2011 Oct 31
Completed
Not Applicable
MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial Start of enrollment: 2012 Jul 12
Active, not recruiting
Not Applicable
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer Start of enrollment: 2013 Apr 04
Recruiting
Not Applicable
Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma Start of enrollment: 2013 Jun 03
Terminated
Phase 2
Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management Start of enrollment: 2012 Aug 01
Withdrawn
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy Start of enrollment: 2016 Jan 05
Terminated
Not Applicable
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy Start of enrollment: 2015 Feb 05
Recruiting
Not Applicable
A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma Start of enrollment: 2022 Sep 21
Recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapy.
Evangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, Veronica Wallaengen, Sandra M Gaston
Physics and Imaging in Radiation Oncology. 2024-10-01
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score.
Helen Y Hougen, Isildinha M Reis, Sunwoo Han, Nachiketh Soodana Prakash, Jamie Thomas
Prostate Cancer and Prostatic Diseases. 2024-09-27
A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Tr...
William Jin, Christopher Montoya, Benjamin James Rich, Crystal Seldon Taswell, Miguel Noy
JMIR Cancer. 2024-09-10

Press Mentions

A Phase III Randomized Trial of MRI-Mapped, Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS TrialJune 28th, 2015
$Radiation Hypofractionation via Extended Versus Accelerated Therapy (HEAT) for Prostate Cancer (HEAT)$
Radiation Hypofractionation via Extended Versus Accelerated Therapy (HEAT) for Prostate Cancer (HEAT)February 18th, 2013